Azitra Inc (AZTR) - Pendapatan lan volume dodolan

Azitra, Inc. (AZTR) develops gene therapies using microbiome proteins to combat dermatological diseases, diversifying risks through a broad pipeline. The absence of sanction threats and operations within US jurisdiction provide a neutral backdrop. The company's sales profile visualizes the market consensus, where 0.00 characterizes this valuation parameter. Business stability is based on the monetization of a unique bacterial drug platform.

AZTR (Azitra, Inc.) riwayat Pendapatan lan volume dodolan saka 21.02.2024 nganti 13.11.2026

Rincian analitis perusahaan Azitra, Inc.

- rega saiki lan proyeksi nilai saham:

Kurs saham Azitra Corporation|AZTR - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar Azitra, Inc.|AZTR - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian nilai buku perusahaan:

Nilai Buku Saham Azitra|AZTR - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku azitrainc.com|AZTR - Gunggung Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang Agregat marang Modal Azitra, Inc.|AZTR - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Azitra Inc|AZTR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Azitra, Inc.|AZTR - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Azitra|Koefisien jangkoan perantara azitrainc.com

- indikator pendapatan resik lan kelipatan nilai:

AZTR - Bathi resik perusahaan|Prakiraan bathi resik Azitra, Inc.|AZTR - Pangali P/E|Prakiraan rega marang bathi azitrainc.com|AZTR - Pangali rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Azitra, Inc.|AZTR - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Azitra|AZTR - Bathi resik saben saham sajrone 12 wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan azitrainc.com|AZTR - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Azitra, Inc.

- statistik dodolan lan pendapatan perusahaan:

AZTR - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Azitra Corporation|AZTR - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Azitra, Inc.

Ringkesan analisis perusahaan:AZTR, Azitra Corporation

Daily revenue monitoring allows for the precise determination of the rate of decline in operating cash flows, preventing the purchase of an overvalued asset at its peak market value. By analyzing the sales dynamics of Azitra, Inc. (AZTR), an investor assesses the effectiveness of the commercialization of its developments, where the flexible allocation of the R&D budget among external laboratories directly impacts product implementation rates and the overall financial stability of the biotech firm.

Perusahaan pesaing

Volume dodolan perusahaan KRYS (Krystal Biotech Corp.)|Pendapatan lan volume dodolan APGE|Pendapatan lan volume dodolan arcutis.com (ARQT)|Vericel - Dodolan perusahaan|ORKA (Oruka Therapeutics, Inc.) - Pendapatan tahunan perusahaan|Sanara - Pendapatan lan volume dodolan|Pendapatan reged perusahaan DBV Technologies S.A. DBVT|SLSN (solesence.com) - Dodolan perusahaan|DERM: Total dodolan perusahaan|Pendapatan perusahaan Forte Biosciences|EMPG: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SLGL|Pendapatan lan volume dodolan reviveprocare.com (AXIL)|Medicus Pharma Ltd. - Dodolan perusahaan|Pendapatan dodolan perusahaan VRCA|Hoth - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Biofrontera Inc. BFRI|vynetherapeutics.com (VYNE) - Pendapatan perusahaan|Volume dodolan perusahaan SNOA|QNRX (Quoin Pharmaceuticals Ltd) - Pendapatan lan volume dodolan|Dodolan perusahaan dermatarx.com (DRMA)|Dodolan perusahaan ELAB (Elevai Labs)|Pendapatan reged perusahaan Revance Therapeutics Inc.